<html>
<head>
<meta http-equiv="Content-Type"; content = "text/html; charset=windows-1250" > 
<title>Sprawozdanie z badañ</title>
<STYLE>.title { FONT-SIZE: 18px; FONT-FAMILY: "Times New Roman" } TD { FONT-SIZE: 11pt } .small { FONT-SIZE: 9pt } a:link { color: #000000; text-decoration: none; } a:visited { color: #000000; text-decoration: none; } a:hover { color: #FF0000;  text-decoration: underline;} .table { BORDER-RIGHT: #000000 0px; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 0px } .td { BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #ffffff 0px; FONT-SIZE: 14px; BORDER-LEFT: #ffffff 0px; BORDER-BOTTOM: #000000 1px solid }  .td2 { BORDER-RIGHT:  #ffffff 0px; BORDER-TOP: #ffffff 0px; FONT-SIZE: 14px; BORDER-LEFT: #ffffff 0px; BORDER-BOTTOM: #000000 1px solid }  .NOPRINT { FONT-SIZE: 9pt; FONT-FAMILY: "Arial" } .wtable { BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid } .lineone { BORDER-RIGHT: #ffffff 0px; BORDER-TOP: #000000 1px solid;  BORDER-LEFT: #ffffff 0px; BORDER-BOTTOM: #000000 1px solid } .lineone1 { BORDER-RIGHT:  #000000 1px solid; BORDER-TOP: #000000 1px solid;  BORDER-LEFT: #ffffff 0px; BORDER-BOTTOM: #000000 1px solid } .three { BORDER-RIGHT: #ffffff 0px; BORDER-TOP: #000000 1px solid;  BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid } .right { BORDER-RIGHT:  #000000 1px solid; BORDER-TOP: #ffffff 0px; BORDER-LEFT: #ffffff 0px; BORDER-BOTTOM: #ffffff 0px } .leftright { BORDER-RIGHT:  #000000 1px solid; BORDER-TOP: #ffffff 0px; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #ffffff 0px } .xtable { BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #ffffff 0px; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid } </STYLE>
</head>
<body style="background:url(Pagebg.jpg);background-position:center">
<table cellSpacing=4 cellPadding=0 width=600 align=Center border=0><tr><td align=middle colspan=3><font size=6>(Tarczyca) Raport z analizy</font></td></tr><tr><td width=100% colspan=3><hr color=#FF9933 size=2></td></tr><tr><td width=30%>Imiê: Szymañska, Aleksandra</td><td width=30% align=center>P³eæ: Kobieta</td><td width=30% align=center>Wiek: 40</td></tr><tr><td colspan=3><table width=100% cellSpacing=0 cellPadding=0 ><tr><td width=50% align=left>Sylwetka: 164cm, 57kg</td><td width=50% align=right>Czas badania: 19.04.2024 19:57</td></tr></table></td></tr><tr><td width=100% colspan=3><hr color=#FF9933 size=2></td></tr></table>
<TABLE width=590 align=center border=0 cellpadding=0 cellspacing=0><tr><td height=8></td></tr></table>
<SCRIPT type='text/javascript' src='echarts.js'></SCRIPT>
<TABLE border=0 width=600 height=100 align=center cellSpacing=0 cellPadding=0><TR><TD bgcolor='ffffff'><div id=R33 style='height:220px; width:600px; margin:0px;'></div></TD></TR><TR><TD bgcolor='ffffff' height=3></TD></TR><TR><TD bgcolor='ffffff'><img src=Ruler.png border=0></TD></TR><TR><TD bgcolor='ffffff' height=18></TD></TR></TABLE>
<SCRIPT type='text/javascript'>
var dom = document.getElementById('R33');
var myChart = echarts.init(dom);
var option = {
grid: { top: 30, bottom: 2,left: 180,right: 30 },
xAxis: { type:'value', max: 6, min: -6,minInterval: 2,
splitLine: { lineStyle: { type: 'dashed' } },
axisLabel : { formatter: function(){ return ''; } } },
yAxis: { type: 'category', axisLine: {show: false}, axisLabel: { interval:0 , formatter : function(params){ var iLong=28; var newString = ''; var iSpace=0; var iNo=0; if(params.length < iLong) { newString = params; }  else{ var strs = params.split(''); for(var i=iLong; i>0; i--){  if(strs[i]==' '){ if(iNo==0){ iSpace=i;iNo=1;} } }  if (iSpace!=0){ newString = params.substring(0,iSpace)+'\n'+params.substring(iSpace+1,params.length); }  else { newString = params; }} return newString; }, textStyle:{ fontSize:11,color:'#000000' }},axisTick: {show: false}, splitLine: {show: true},
data: ['Trójjodotyronina (FT3)','Przeciwcia³a przeciwko L-Tyroksynie','L-Tyroksyna','Poziom wolnej tyrokysny (FT4)']},
series: [{ type: 'bar',
data: ['3','-1','3','3'],
itemStyle:{ normal:{  color: function (params){
var colorList = ['#2861C8','#6CE26C','#2861C8','#2861C8'];
return colorList[params.dataIndex]; } } }
 }]
};
 if (option && typeof option === 'object') {
myChart.setOption(option, true); }
</SCRIPT>
<TABLE width=590 align=center border=0 cellpadding=0 cellspacing=0><tr><td height=15></td></tr></table>
<TABLE width=590 align=center border=0><TR><TD><Font size=3><STRONG>Aktualne badane wyniki</STRONG></Font></TD></TR></TABLE><TABLE class=table cellSpacing=0 cellPadding=3 width=590 align=center border=0><TR class=td align=middle bgcolor=B3D9ED height=28><TD class=td><STRONG>Badane pozycje</STRONG></TD><TD class=td><STRONG>Norma warto&#347;ci</STRONG></TD><TD class=td><STRONG>Badane warto&#347;ci</STRONG></TD><TD class=td><STRONG>Wynik badania</STRONG></TD></TR><TR class=td align=left bgcolor=EBF5FB><TD class=td align=middle>Poziom wolnej tyrokysny (FT4)</TD><TD class=td align=middle>0,103 - 0,316</TD><TD class=td align=middle>0,453</TD><TD class=td align=middle><image src=YC05.png border=0></TD></TR><TR class=td align=left bgcolor=EBF5FB><TD class=td align=middle>L-Tyroksyna</TD><TD class=td align=middle>0,114 - 0,202</TD><TD class=td align=middle>0,375</TD><TD class=td align=middle><image src=YC05.png border=0></TD></TR><TR class=td align=left bgcolor=EBF5FB><TD class=td align=middle>Przeciwcia&#322;a przeciwko L-Tyroksynie</TD><TD class=td align=middle>0,421 - 0,734</TD><TD class=td align=middle>0,598</TD><TD class=td align=middle><image src=YC04.png border=0></TD></TR><TR class=td align=left bgcolor=EBF5FB><TD class=td align=middle>Trójjodotyronina (FT3)</TD><TD class=td align=middle>0,161 - 0,308</TD><TD class=td align=middle>0,429</TD><TD class=td align=middle><image src=YC05.png border=0></TD></TR></TABLE>
<TABLE width=590 align=center border=0 cellpadding=0 cellspacing=0><tr><td height=20></td></tr></table>
<TABLE cellSpacing=0 cellPadding=3 width=590 align=center border=0><TR align=middle><TD><b>Standard referencyjny:</b></TD><TD colspan=2><TABLE cellSpacing=0 cellPadding=0 border=0><TR><TD><img src=YCMark4.jpg border=0>&nbsp;</TD><TD><B>Norma(-)</B></TD><TD><img src=YCMark3.jpg border=0>&nbsp;</TD><TD><B>Nieznacznie poza norm&#261;(+)</B></TD></TR><TR><TD><img src=YCMark2.jpg border=0>&nbsp;</TD><TD><B>&#346;rednie odst&#281;pstwo(++)</B></TD><TD><img src=YCMark1.jpg border=0>&nbsp;</TD><TD><B>Powa&#380;ne odst&#281;pstwo(+++)</B></TD></TR></TABLE></TD></TR><TR><TD colspan=3 height=8> </TD></TR><TR align=middle><TD>Poziom wolnej tyrokysny (FT4):</TD><TD>0,103-0,316(-)</TD><TD>0,316-0,645(+)</TD></TR><TR align=middle><TD>&nbsp;</TD><TD>0,645-0,873(++)</TD><TD>>0,873(+++)</TD></TR><TR><TD colspan=3 height=8> </TD></TR><TR align=middle><TD>L-Tyroksyna:</TD><TD>0,114-0,202(-)</TD><TD>0,202-0,447(+)</TD></TR><TR align=middle><TD>&nbsp;</TD><TD>0,447-0,627(++)</TD><TD>>0,627(+++)</TD></TR><TR><TD colspan=3 height=8> </TD></TR><TR align=middle><TD>Przeciwcia&#322;a przeciwko L-Tyroksynie:</TD><TD>0,421-0,734(-)</TD><TD>0,323-0,421(+)</TD></TR><TR align=middle><TD>&nbsp;</TD><TD>0,210-0,323(++)</TD><TD><0,210(+++)</TD></TR><TR><TD colspan=3 height=8> </TD></TR><TR align=middle><TD>Trójjodotyronina (FT3):</TD><TD>0,161-0,308(-)</TD><TD>0,308-0,543(+)</TD></TR><TR align=middle><TD>&nbsp;</TD><TD>0,543-0,757(++)</TD><TD>>0,757(+++)</TD></TR><TR><TD colspan=3 height=8> </TD></TR></TABLE>
<TABLE width=590 align=center border=0 cellpadding=0 cellspacing=0><tr><td height=30></td></tr></table>
<TABLE class=wtable cellSpacing=4 cellPadding=3 width=590 align=center border=0 bgcolor=B3D9ED><TR><TD align=center><B>Opis parametrów</B></TD></TABLE><TABLE class=xtable cellSpacing=4 cellPadding=0 width=590 align=center border=0 bgcolor=EBF5FB><TR><TD><B>Poziom wolnej tyrokysny (FT4):</B></TD></TR><TR><TD>jest czu&#322;ym wska&#378;nikiem czynno&#347;ci tarczycy &#347;wiadcz&#261;cym o tzw.zapasie wolnej tetrajodotyroniny stanowi&#261;cej materia&#322; wyj&#347;ciowy do wytworzenia FT3. Zaburzony poziom skutkuje niedoczynno&#347;ci&#261; lub nadczynno&#347;ci&#261; tarczycy.</TD></TR></TABLE><TABLE class=xtable cellSpacing=4 cellPadding=0 width=590 align=center border=0 bgcolor=EBF5FB><TR><TD><B>L-Tyroksyna:</B></TD></TR><TR><TD>jest&nbsp;glikoprotein&#261;, hormonalnym bia&#322;kiem produkowanym wy&#322;&#261;cznie przez komórki p&#281;cherzykowe&nbsp;tarczycy, zarówno prawid&#322;owe, jak i&nbsp;nowotworowo zmienione. W surowicy zdrowych osób wykrywa si&#281; Tg w st&#281;&#380;eniu 2-70&nbsp;ng/ml. Tyreoglobulina zawiera&nbsp;trijodotyronin&#281;&nbsp;oraz&nbsp;tyroksyn&#281; (tetrajodotyronin&#281;).Poniewa&#380; tyreoglobulina jest produkowana przez niemal wszystkie typy zró&#380;nicowanego&nbsp;raka tarczycy, powszechnie wykorzystywana jest jako&nbsp;marker tego nowotworu.</TD></TR></TABLE><TABLE class=xtable cellSpacing=4 cellPadding=0 width=590 align=center border=0 bgcolor=EBF5FB><TR><TD><B>Przeciwcia&#322;a przeciwko L-Tyroksynie:</B></TD></TR><TR><TD>Wysokie miano przeciwcia&#322; wskazuje na obecno&#347;&#263; autoimmunologicznej choroby tarczycy, ale nie rozstrzyga o typie tej choroby; Przeciwcia&#322;a antyperoksydazowe wyst&#281;puj&#261; u 95% pacjentów z chorob&#261; Hashimoto i u 85% pacjentów z chorob&#261; Graves-Basedowa, lecz stwierdza si&#281; je równie&#380; (przej&#347;ciowo) w podostrym zapaleniu tarczycy.</TD></TR></TABLE><TABLE class=xtable cellSpacing=4 cellPadding=0 width=590 align=center border=0 bgcolor=EBF5FB><TR><TD><B>Trójjodotyronina (FT3):</B></TD></TR><TR><TD>organiczny zwi&#261;zek chemiczny,&nbsp;trójjodowa&nbsp;pochodna&nbsp;tyroniny.&nbsp;Hormon&nbsp;wytwarzany przez komórki p&#281;cherzyków&nbsp;tarczycy, magazynowany w postaci&nbsp;tyreoglobuliny&nbsp;i wydzielany do&nbsp;krwiobiegu.</TD></TR></TABLE>
<TABLE width=590 align=center border=0 cellpadding=0 cellspacing=0><tr><td height=12></td></tr></table>
<table cellSpacing=0 cellPadding=0 width=600 align=Center border=0><tr><td><hr color=#FF9933 size=2></td></tr></table>
<TABLE cellSpacing=0 cellPadding=0 width=590 align=center border=0><TR height=5><TD></TD></TR><TR align=right><TD colSpan=2>Wyniki testu s&#261; jedynie orientacyjne i nie stanowi&#261; ko&#324;cowej diagnozy.</TD></TR></table>
</body>
</html>
